Physician profile
Pankaj Mehta
NPI 1073787909
$2,112,181.29
in general payments reported to CMS, 2019-2025
35 companies · $229K in 2025
The $229K reported for 2025 was more than what 99% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $360K · 2020: $307K · 2021: $320K · 2022: $406K · 2023: $205K · 2024: $285K · 2025: $229K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $385K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $158K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $56K · Travel and Lodging: $43K · Royalty Or License: $38K · Food and Beverage: $25K · Education: $14K · Entertainment: $63.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $385,048.27 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $158,286.25 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $56,318.75 |
| Travel and Lodging | $42,651.44 |
| Royalty Or License | $37,532.47 |
| Food and Beverage | $24,825.81 |
| Education | $13,943.75 |
| Entertainment | $63.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $967,995.48 | 2019-2025 | Proclaim, Eterna, Octrode |
| Boston Scientific Corporation | $355,610.63 | 2019-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Intracept |
| Aurora Spine, INC. | $324,131.17 | 2023-2025 | Zip, Discovery Tinano Acif |
| Vertiflex, INC. | $186,905.36 | 2019 | |
| Spinal Simplicity, LLC | $144,380.11 | 2020-2025 | Ha Minuteman G3-R |
| Relievant Medsystems, INC. | $49,031.47 | 2020-2023 | Intracept |
| Surgentec | $37,009.54 | 2023-2025 | Ion Facet Screw System, Tilinki, Ion |
| Painteq LLC | $24,609.45 | 2021-2024 | Painteq |
| Spr Therapeutics, INC | $10,622.10 | 2019-2023 | Sprint Pns System |
| Foundation Fusion Solutions, LLC | $2,158.76 | 2020-2023 | |
| Nevro Corp. | $2,017.30 | 2019-2024 | Senza |
| Spinefrontier, INC. | $1,839.45 | 2025 | Inspan, Sijfuse, Nanofuse |
| Medtronic, INC. | $1,815.76 | 2021-2025 | Intellis Adaptivestim |
| Globus Medical, INC. | $683.87 | 2025 | Senza, Omnia, Vyrsa V1 |
| Biotronik Nro, INC. | $583.77 | 2023-2024 | Biotronik, Prospera |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nalu Medical, INC. | $561.56 | 2020-2025 | Nalu Neurostimulation System |
| Mml US, INC. | $506.89 | 2021 | |
| Vertos Medical, INC. | $270.10 | 2019-2023 | Mild Device Kit |
| Saluda Medical Americas, INC. | $239.31 | 2024-2025 | Evoke |
| Si-Bone, INC. | $192.97 | 2019-2024 | |
| Curonix LLC | $161.29 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $145.98 | 2022 | |
| Zynex Medical, INC. | $131.05 | 2025 | Nexwave |
| Riwospine, INC. | $131.03 | 2024 | Spine |
| Wenzel Spine, INC. | $117.75 | 2025 | Primalok |
| Flowonix Medical Incorporated | $80.00 | 2019 | |
| Fujifilm Sonosite, INC. | $77.50 | 2019 | |
| Stimwave Technologies Incorporated | $43.52 | 2019 | |
| Grt US Holding, INC. | $32.24 | 2021-2022 | |
| Scilex Pharmaceuticals INC. | $22.37 | 2019 | |
| Hydrocision, INC. | $16.70 | 2020 | |
| Abbvie INC. | $15.57 | 2021 | |
| Medtronic USA, INC. | $15.10 | 2019 | |
| Davol INC. | $14.32 | 2023 | Arista Ah Flexitip |
| Arbor Pharmaceuticals, INC. | $11.82 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$58,027.47 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pankaj Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.